Reconstructive Tissue Surgery Clinical Trial
Official title:
Glucose Monitoring in Tissue Transfers
| Verified date | March 2018 |
| Source | University of Wisconsin, Madison |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to determine if 1) a continuous glucose monitoring system can measure glucose levels in transferred tissue during reconstructive surgery, and 2) if glucose measurements from a continuous glucose monitoring system correlate with tissue blood perfusion.
| Status | Withdrawn |
| Enrollment | 0 |
| Est. completion date | June 2011 |
| Est. primary completion date | June 2011 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - presence of a soft tissue deformity where reconstruction with a pedicled or free tissue transfer is indicated - age 18 and over - ability to follow-up post-operatively Exclusion Criteria: - age less than 18 - prisoner status - inability to participate in a standard post-operative follow-up visit |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Wisconsin | Madison | Wisconsin |
| Lead Sponsor | Collaborator |
|---|---|
| University of Wisconsin, Madison |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Perfusion and tissue transfer outcome during reconstructive surgery predicted by continuous glucose monitoring of tissue | Up to three days post-op |